Filing Details
- Accession Number:
- 0001209191-19-015316
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-04 10:29:23
- Reporting Period:
- 2019-02-27
- Accepted Time:
- 2019-03-04 10:29:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1626878 | Xbiotech Inc. | XBIT | () | 1231 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1094515 | Fondation Rennes | R?Tikonstrasse 13 Vaduz N2 FL-9490 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-27 | 5,273 | $8.13 | 3,853,555 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-02-28 | 5,302 | $8.19 | 3,858,857 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-03-01 | 34,999 | $8.13 | 3,893,856 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.23, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.99 to $8.31, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.94 to $8.25, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Number is revised to include 150,000 shares which were inadvertently omitted from prior filings.
Billionaire Hedge Funds
